Effectiveness of Mindfulness-Based Interventions to Reduce Stress in Patients With MS
June 5th 2023At the 2023 CMSC Annual Meeting, Christopher C. Hemond, MD, assistant professor of neurology at UMass Chan Medical School, provided an overview of his study on mindfulness-based stress reduction in patients with MS using MRI and patient outcomes.
New Insights on Discovering Targeted Therapies for Progressive MS: Anne H. Cross, MD
June 4th 2023The professor of neurology at Washington University School of Medicine discussed progressive multiple sclerosis and the need for targeted therapies to address the progression and associated challenges. [WATCH TIME: 5 minutes]
Challenges and Advancements in Biomarkers for Accurate Diagnosis in MS: Andrew Solomon, MD
June 3rd 2023At CMSC 2023, the associate professor of neurological sciences at the University of Vermont in Burlington talked about data surrounding multiple sclerosis diagnosis and misdiagnosis, suggesting the need for the development of diagnostic biomarkers. [WATCH TIME: 5 minutes]
NeurologyLive® and CMSC Announce Giants of Multiple Sclerosis® 2023 Class of Inductees
April 26th 2023Giants of Multiple Sclerosis is a premier neuroscience award that celebrates pioneers, innovators, and difference makers who have been selected by their peers for their remarkable achievements in multiple sclerosis.
MS TeamWorks Inspirational Videos for the Multiple Sclerosis Community Reaches Milestone
November 10th 2022Contact: Annie Scully, annie.scully@mscare.org, 201-310-9252 MS TeamWorks Inspirational Videos for the Multiple Sclerosis Community Reaches Viewer Milestone Video Series Featuring Diverse Voices of MS Hope and Insight Records More than 200,000 Views
Peers & Perspectives: The Induction vs Escalation Approach to MS and the TREAT-MS Trial
July 12th 2022Scott Newsome, DO, and Ellen Mowry, MD, discuss the ongoing TREAT-MS trial and its goals, the importance of the findings for clinical practice in multiple sclerosis, and the ongoing discussion around induction vs escalation in MS treatment. [WATCH TIME: 24 minutes]
Properly Assessing Cognition in Patients With Multiple Sclerosis: John DeLuca, PhD
July 4th 2022The senior vice president for research and training at the Kessler Foundation discussed the assessment of cognitive challenges among patients with multiple sclerosis and planning for treatment options when necessary. [WATCH TIME: 4 minutes]
Regularly Measuring Cognition in MS, and Treating Cognitive Issues: John DeLuca, PhD
July 1st 2022The senior vice president for research and training at the Kessler Foundation spoke about the critical need to prioritize cognitive challenges among patients with multiple sclerosis, as it remains among the chief complaints. [WATCH TIME: 4 minutes]
Expanding the Use of Spinal Cord Atrophy in Multiple Sclerosis: Blake E. Dewey, PhD
June 4th 2022The postdoctoral researcher at the Johns Hopkins Multiple Sclerosis Center shared his perspective on the use of spinal cord atrophy in clinical practice to measure disease progression in MS and how it might become more accessible. [WATCH TIME: 4 minutes]
Women With MS Use Social Media to Augment Knowledge and Support: Riley Bove, MD
June 2nd 2022The associate professor of neurology at UCSF Weill Institute for Neurosciences discussed the findings of a social media listening study that suggested women with multiple sclerosis used social media platforms to discuss treatment during and around pregnancy. [WATCH TIME: 4 minutes]
EHR-Incorporated MS Smartform Significantly Cuts Down Patient History Review Time in MS
June 2nd 2022The form, which is freely available through the Epic and Cerner EHR platforms, was developed to streamline and standardize patient data collection to allow clinicians more time with patients and more consistent information.
Women With MS Utilize Social Media to Discuss, Share Safety Concerns on DMT Use During Pregnancy
June 1st 2022Investigators utilized a social media listening tool to evaluate and scale mentions of disease-modifying therapy use by women with multiple sclerosis, with the majority of concerns focused on safety and treatment reinitiation in the postpartum period.